posted on 2016-12-13, 16:04authored byS. L. Thein1, D. G. Oscier, A. J. Jeffreys, C. Hesketh, S. Pilkington, C. Summers, M. Fitchett, J. S . Wainscoat
Chromosomal loss is a characteristic feature of the myelodysplastic syndromes (MDS). A method is described which detects chromosomal 7 loss in MDS by DNA analysis using a specific hypervariable region gene probe which has been cloned from a human DNA fingerprint. Loss of one of the chromosomal 7 homologues was demonstrated in 10/118 MDS patients; the ten patients include all the five patients which had previously been shown to have monosomy 7 by cytogenetic analysis. This technique makes it feasible to study serial samples from large numbers of patients for loss of chromosomal material and could be readily applied to the study of other human malignancies.
Funding
SLT is a Wellcome Senior Research
Fellow in Clinical Science. JSW is supported in part by the
Leukaemia Research Fund.
History
Citation
British Journal of Cancer (1988) 57, 131–134
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/MBSP Non-Medical Departments/Department of Genetics